Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2Cr.3O4S.15H2O |
| Molecular Weight | 662.409 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O
InChI
InChIKey=BWSOELSKLHYQRA-UHFFFAOYSA-H
InChI=1S/2Cr.3H2O4S.15H2O/c;;3*1-5(2,3)4;;;;;;;;;;;;;;;/h;;3*(H2,1,2,3,4);15*1H2/q2*+3;;;;;;;;;;;;;;;;;;/p-6
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Cr |
| Molecular Weight | 51.9961 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O4S |
| Molecular Weight | 98.078 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0004714 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | CHROMIUM Approved UseChromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. Launch Date2005 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The peripheral quantitative computed tomographic and densitometric analysis of skeletal tissue in male Wistar rats after chromium sulfate treatment. | 2017-09-21 |
|
| Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: a biochemical and histopathological study in male rats. | 2007-11 |
|
| Immunosuppressive effect of subchronic exposure to a mixture of eight heavy metals, found as groundwater contaminants in different areas of India, through drinking water in male rats. | 2007-10 |
|
| Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium. | 2007-08 |
|
| The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+. | 2005-12-01 |
|
| Status of antioxidant defense system in chromium-induced Swiss mice tissues. | 2004-07 |
|
| Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate. | 1999-12 |
|
| Activation of MAPKs in human bronchial epithelial cells exposed to metals. | 1998-09 |
|
| Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity. | 1996-03 |
|
| Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. | 1994-06 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:47:07 GMT 2025
by
admin
on
Mon Mar 31 18:47:07 GMT 2025
|
| Record UNII |
E4T8TU3LE8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
E4T8TU3LE8
Created by
admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
|
PRIMARY | |||
|
DTXSID60905345
Created by
admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
|
PRIMARY | |||
|
10031-37-5
Created by
admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
|
PRIMARY | |||
|
1875238
Created by
admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
|
PRIMARY | |||
|
197887
Created by
admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
|
PRIMARY | |||
|
E4T8TU3LE8
Created by
admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ANHYDROUS->SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
